RE:RE:How are we going to knowKaddyshack wrote: I'm excited to see how much traction JT gets during the conference and the outcome... I think SZLS and the rest of the market is shadowed by what's happening with GME/AMC/NAKD/NOK etc and the short selling frenzy in the US. No news for SZLS as usual but hopefully we don't fall too far behind where the postive momentum has taken us with Ichor and other partners.... I do not think we will be affected as much by what's going on in the world markets but it def takes the light off SZLS right now... not to mention all the restrictions travellers now face just trying to get back to Canada (who has the Gov't deals/partnerships right now??)
anyone else want to chime in?
Ultimately, Aristotle has to sell itself on its own merits. A conference like this will showcase a "to market anytime" opportunity. Tripp can highlight that it was selected for publication in the past and ergo has already been recognized. Participants are sauvy and always looking for ground breaking technologies in high profile healthcare sectors and Aristotle checks all the boxes. One would think that with the great market success of Grail/Exas etc. that they would recognize the investment opportunity at hand. Sure, the likes of AMC/GMC will make for some great sidleline conversations, but ultimately participants are there to identify real and affordable opportunities.